Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-C motif chemokine ligand 3 (CCL3), commonly known as macrophage inflammatory protein 1-alpha (MIP-1-alpha), is a small secreted cytokine belonging to the CC chemokine family. It plays a central role in acute and chronic inflammatory responses by recruiting and activating immune cells, such as macrophages, neutrophils, and lymphocytes, primarily through binding to chemokine receptors CCR1, CCR4, and CCR5. CCL3 shows potent chemoattractant and inflammatory properties, including fever induction and stem cell proliferation inhibition, and is directly implicated in infectious diseases (including HIV/AIDS), autoimmune disorders, and bone metabolism. Clinically, it serves as a marker of inflammation and as a potential therapeutic target in inflammatory and infectious disease, with ongoing investigation into chemokine receptor antagonists for disease modulation
Inhibition of HIV entry via competitive binding to CCR5 receptor (CCR5 antagonists) CCR1 antagonists reduce inflammatory cell recruitment by blocking CCL3-CCR1 interaction Modulation of immune cell chemotaxis via blockade of CCR1, CCR4, or CCR5
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C motif chemokine ligand 3 (CCL3).